Search research articles
Contact Us
Filters
Showing results (71-80 of 137) with videos related to
Page
of 14
Sort By:
Cell Reports
|
August 20, 2023
IL-2 can signal via chemokine receptors to promote regulatory T cells' suppressive function
Hao Sun, Ho-Sup Lee, Sarah Hyun-Ji Kim, et al.
Annals of Hematology
|
April 6, 2018
Bendamustine plus rituximab for relapsed or refractory diffuse large B cell lymphoma: a multicenter retrospective analysis
Jung Yong Hong, Dok Hyun Yoon, Cheolwon Suh, et al.
Blood Research
|
April 17, 2013
Current routine practice and clinico-pathological characteristics associated with acute promyelocytic leukemia in Korea
Sunhyun Ahn, Joon Seong Park, Seong Hyun Jeong, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
November 18, 2011
Incidence rates and risk factors for vascular events in patients with essential thrombocythemia: a multicenter study from Korea
Ho Sup Lee, Lee Chun Park, Eun Mi Lee, et al.
Cancer Research and Treatment
|
July 22, 2014
Clinical Usefulness of Hydromorphone-OROS in Improving Sleep Disturbances in Korean Cancer Patients: A Multicenter, Prospective, Open-Label Study
Seong Hoon Shin, Ho Sup Lee, Yang Soo Kim, et al.
British Journal of Haematology
|
November 28, 2025
A multicentre prospective phase II study of rituximab combined with bortezomib, lenalidomide and dexamethasone, followed by lenalidomide maintenance (R-VRD) in patients with Waldenström's macroglobulinaemia (KMM1803)
Sung-Hoon Jung, Dajung Kim, Je-Jung Lee, et al.
Scientific Reports
|
July 17, 2020
Prognostic significance of interim PET/CT response for the treatment of advanced-stage marginal zone lymphoma in the post-rituximab era
Ga-Young Song, Sang Eun Yoon, Seok Jin Kim, et al.
Oncotarget
|
November 8, 2017
Can we consider discontinuation of hypomethylating agents in patients with myelodysplastic syndrome : a retrospective study from The Korean Society of Hematology AML/MDS Working Party
Da Jung Kim, Ho Sup Lee, Joon-Ho Moon, et al.
Annals of Hematology
|
April 8, 2016
The clinical impact of thalidomide maintenance after autologous stem cell transplantation in patients with newly diagnosed multiple myeloma in real clinical practice of Korea
Ho Sup Lee, Chang-Ki Min, Je-Jung Lee, et al.
Annals of Hematology
|
December 20, 2019
Clinical features and treatment outcomes of limited-stage mantle cell lymphoma: Consortium for Improving Survival of Lymphoma report
Jae-Cheol Jo, Seok Jin Kim, Ho Sup Lee, et al.
Page
of 14
Search research articles
Search
Showing results (71-80 of 137) with videos related to
Sort By:
Page
of 14
Cell Reports
|
August 20, 2023
IL-2 can signal via chemokine receptors to promote regulatory T cells' suppressive function
Hao Sun, Ho-Sup Lee, Sarah Hyun-Ji Kim, et al.
Annals of Hematology
|
April 6, 2018
Bendamustine plus rituximab for relapsed or refractory diffuse large B cell lymphoma: a multicenter retrospective analysis
Jung Yong Hong, Dok Hyun Yoon, Cheolwon Suh, et al.
Blood Research
|
April 17, 2013
Current routine practice and clinico-pathological characteristics associated with acute promyelocytic leukemia in Korea
Sunhyun Ahn, Joon Seong Park, Seong Hyun Jeong, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
November 18, 2011
Incidence rates and risk factors for vascular events in patients with essential thrombocythemia: a multicenter study from Korea
Ho Sup Lee, Lee Chun Park, Eun Mi Lee, et al.
Cancer Research and Treatment
|
July 22, 2014
Clinical Usefulness of Hydromorphone-OROS in Improving Sleep Disturbances in Korean Cancer Patients: A Multicenter, Prospective, Open-Label Study
Seong Hoon Shin, Ho Sup Lee, Yang Soo Kim, et al.
British Journal of Haematology
|
November 28, 2025
A multicentre prospective phase II study of rituximab combined with bortezomib, lenalidomide and dexamethasone, followed by lenalidomide maintenance (R-VRD) in patients with Waldenström's macroglobulinaemia (KMM1803)
Sung-Hoon Jung, Dajung Kim, Je-Jung Lee, et al.
Scientific Reports
|
July 17, 2020
Prognostic significance of interim PET/CT response for the treatment of advanced-stage marginal zone lymphoma in the post-rituximab era
Ga-Young Song, Sang Eun Yoon, Seok Jin Kim, et al.
Oncotarget
|
November 8, 2017
Can we consider discontinuation of hypomethylating agents in patients with myelodysplastic syndrome : a retrospective study from The Korean Society of Hematology AML/MDS Working Party
Da Jung Kim, Ho Sup Lee, Joon-Ho Moon, et al.
Annals of Hematology
|
April 8, 2016
The clinical impact of thalidomide maintenance after autologous stem cell transplantation in patients with newly diagnosed multiple myeloma in real clinical practice of Korea
Ho Sup Lee, Chang-Ki Min, Je-Jung Lee, et al.
Annals of Hematology
|
December 20, 2019
Clinical features and treatment outcomes of limited-stage mantle cell lymphoma: Consortium for Improving Survival of Lymphoma report
Jae-Cheol Jo, Seok Jin Kim, Ho Sup Lee, et al.
Page
of 14